DNAe Launches Early Access Program for NGS Diagnostic Platform
Hospital teams can trial the company's BSI/AMR test and preview the LiDia-SEQ system ahead of commercial launch.
Tag: NGS
All
Latest
All
Latest
Rapid NGS Technology Accelerates Clinical Trial Breakthroughs in Oncology
Precision oncology is undergoing rapid transformation driven by NGS technology, but systemic barriers in testing access must be overcome.
All
Latest
Biofidelity to Launch Enspyre Technology
Biofidelity is launching Enspyre, a novel target enrichment technology that significantly enhances NGS efficiency.
CMS Finalizes 2025 Pricing for 3D Genomics Cancer Test
Aventa Genomics received CMS approval for Clinical Laboratory Fee Schedule pricing of an NGS tool that uses 3D genomics for cancer testing.
Read More
Biofidelity’s Aspyre Lung Delivers Accurate Molecular Diagnostics for NSCLC Variants
Studies validated Biofidelity’s Aspyre Lung diagnostic tech, showcasing its ability to offer genomic profiling for actionable NSCLC variants.
Read More
How mNGS Testing Delivers Unmatched Pathogen Detection in Infectious Diseases
Delve Bio found that mNGS identified more pathogens from cerebrospinal fluid samples than all conventional diagnostic methods combined.
Read More
AMP Releases Best Practices Report for SARS-CoV-2 Genomic Surveillance Using NGS Tech
The AMP published a consensus report on best practices for SARS-CoV-2 genomic surveillance using next-generation sequencing (NGS).
Read More
Biotia’s Genomics-Based Urine Test Gains New York State Approval
Biotia’s BIOTIA-ID Urine NGS Assay uses artificial intelligence (AI) and genomics to deliver rapid, highly accurate UTI diagnoses.
Read More
NeoGenomics’ Solid Tumor Test Gets New York State Approval
NeoGenomics received conditional approval from the New York State Department of Health for its Neo Comprehensive Solid Tumor and NeoTYPE DNA & RNA Lung assays.
Read More
Illumina Launches New Series of Benchtop Sequencing Systems
Illumina’s new MiSeq i100 Series sequencing systems provide faster, simpler, and more cost-efficient next-generation sequencing solutions.
Read More
Healthcare-Associated Infections Can Be Reduced with DNA Sequencing
Reducing the incidence of healthcare-associated infections, and the antimicrobial resistance they can trigger, is critical for patient care.
Read More
New Partnership to Expand Access to Metagenomic Sequencing for Neurological Infections
Delve Bio partnered with Broad Clinical Labs to accelerate commercialization and accessibility of mNGS for diagnosing neurological infection.
Read More
AstraZeneca and Pillar Biosciences Partner to Accelerate Access to Liquid Biopsy Testing
Pillar Biosciences and AstraZeneca seek to expand access to NGS-based liquid biopsy tumor profiling to detect genetic cancer variants.
Read More
Prenatal Genetic Screening Won’t Lead to ‘Designer Babies’
Gattaca Genomics aims to enhance family-building through advanced prenatal genetic screening, increasing the success rates and access.
Read More
Cell-Based Non-Invasive Prenatal Test Uses Simple Maternal Blood Draw
Menarini Silicon Biosystems presented a study, about its advanced non-invasive prenatal testing technology using maternal blood.
Read More
Bio-Rad Launches New RNA-Seq Kit for Single-Cell Gene Expression
Bio-Rad Labs’s new ddSEQ Single-Cell 3′ RNA-Seq Kit and Omnition v1.1 analysis software enhances single-cell gene expression research.
Read More
New Global Partnership Enhances NGS for Advanced Cancer Research
Integrated DNA Technologies and Molecular Health entered into a global multi-year agreement to integrate their NGS capabilities.
Read More
OGT Launches New Panel for Myeloid Cancer
OGT launched a new next-generation sequencing (NGS) tool designed to identify key fusion genes associated with acute myeloid leukemia (AML).
Read More